DC-MED Michał Kowalski S.K.
- Address
- ul. Kilińskiego 6, 26-610 Radom, Poland
Digestive System Diseases
Clinical research at DC-MED Michał Kowalski S.K. includes studies in digestive system diseases, with a focus on ulcerative colitis and related inflammatory bowel conditions. The trials are designed to evaluate how well new treatment options perform compared with established therapies and to support better care for people living with chronic intestinal inflammation.
- Comparing a proposed biosimilar with an existing treatment for moderate to severe active ulcerative colitis
- Assessing treatment effectiveness in inflammatory bowel disease
These studies aim to help confirm whether new therapies can offer similar benefits to current standards while expanding options for patients with difficult-to-control digestive disorders.
Immune System Diseases
The site also supports research in immune system diseases, especially conditions such as Crohn’s disease and severe forms of ulcerative colitis. This work reflects a broader effort to understand and improve treatment for chronic inflammatory diseases that affect the body's immune response.
- Studying ulcerative colitis and Crohn’s disease as immune-mediated conditions
- Measuring medicine levels in breast milk for lactating participants receiving mirikizumab
Research here includes both evaluation of treatment performance and questions about medicine use in special populations, helping inform safer and more effective care in immune-mediated disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Eli Lilly & Co.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in DC-MED Michał Kowalski S.K.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Efficacy, Safety, and Immunogenicity of Intravenous AVT16 Versus Vedolizumab in Adults with Moderate to Severe Active Ulcerative Colitis | Alvotech Swiss AG | Phase III | Not Recruiting | Aug 2025 | Oct 2025 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Mirikizumab | 1 | Unknown | 2026-06-08 | 2026-06-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.